Societies

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Societies

ESMO Guideline: Oncogene-Addicted mNSCLC – The European Society for Medical Oncology (ESMO)

Photo taken from esmo.org/guidelines

Jan 10, 2024, 11:54

ESMO Guideline: Oncogene-Addicted mNSCLC – The European Society for Medical Oncology (ESMO)

The European Society for Medical Oncology (ESMO) posted on X/Twitter:

“ESMO Guideline: Oncogene-Addicted mNSCLC. Developed due 2 advances in biomarker identification and targeted therapies; updated recommendations and treatment algorithms on new and clinically relevant biomarker identification, targeting and advanced disease management.”

View additional information.
Source: The European Society for Medical Oncology (ESMO)/X

advances in biomarker identification cancer ESMO Guideline mNSCLC OncoDaily Oncology targeted therapies The European Society for Medical Oncology (ESMO) treatment algorithms

Aug 17, 2024, 20:21

Dunkley’s will be lacing up their walking shoes for the Shine Night Walk in Bristol in support of Cancer Research UK - Dunkley's Chartered Accountants

Aug 17, 2024, 20:10

CANCaRe Africa's Voice of the families: Gashanew and his father

Aug 17, 2024, 20:07

Roche Africa CEO recently spoke of the care gap that exists throughout the African continent

Aug 17, 2024, 20:01

Miriam Mutebi: Cancer fatalism—the belief that cancer is incurable

Aug 17, 2024, 19:56

Oncotype DX Colon Recurrence Score in stage II colon cancer, summary by Erman Akkus

Aug 17, 2024, 19:53

First European Patient Dosed in Phase I Trial Of Novel CD30-Directed ADC FOR Lymphomas - The START Center for Cancer Research

Aug 17, 2024, 19:47

Marc Braunstein: Updates on CAR T-cell therapy in myeloma

Aug 17, 2024, 16:35

Matti Aapro is running for the UICC Board of Directors

Aug 17, 2024, 16:27

HICCC Welcomes New DEI Assistant Directors

Aug 17, 2024, 16:18

Research Associate/Postdoc position open at the CRTD

Aug 17, 2024, 16:11

Misty Dawn Shields: Proud of The Shields Lab team and the work being done in the fight against SCLC

Aug 17, 2024, 16:03

Johns Hopkins engineers have created a new optical tool that could improve cancer imaging - Johns Hopkins Medicine International